Mega Uranium Ltd.
Mega Uranium Ltd. Fundamental Analysis
Mega Uranium Ltd. (MGAFF) shows weak financial fundamentals with a PE ratio of 24.76, profit margin of 0.00%, and ROE of 3.98%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 29.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MGAFF's fundamental strength across five key dimensions:
Efficiency Score
WeakMGAFF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentMGAFF trades at attractive valuation levels.
Growth Score
ModerateMGAFF shows steady but slowing expansion.
Financial Health Score
ExcellentMGAFF maintains a strong and stable balance sheet.
Profitability Score
WeakMGAFF struggles to sustain strong margins.
Key Financial Metrics
Is MGAFF Expensive or Cheap?
P/E Ratio
MGAFF trades at 24.76 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, MGAFF's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Mega Uranium Ltd. at 0.79 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 44.22 times EBITDA. This signals the market has high growth expectations.
How Well Does MGAFF Make Money?
Net Profit Margin
For every $100 in sales, Mega Uranium Ltd. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.98 in profit for every $100 of shareholder equity.
ROA
Mega Uranium Ltd. generates $2.80 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.01 in free cash annually.
FCF Yield
MGAFF converts -2.18% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
24.76
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.79
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.07
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.28
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
-0.01
vs 25 benchmark
How MGAFF Stacks Against Its Sector Peers
| Metric | MGAFF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 24.76 | 21.16 | Worse (Expensive) |
| ROE | 3.98% | 975.00% | Weak |
| Net Margin | 0.00% | -58736.00% (disorted) | Weak |
| Debt/Equity | 0.07 | -0.49 (disorted) | Distorted |
| Current Ratio | 1.28 | 5.15 | Neutral |
| ROA | 2.80% | -11053687.00% (disorted) | Weak |
MGAFF outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Mega Uranium Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.00%
Industry Style: Cyclical, Value, Commodity
DecliningEPS CAGR
-8.86%
Industry Style: Cyclical, Value, Commodity
DecliningFCF CAGR
-81.24%
Industry Style: Cyclical, Value, Commodity
Declining